Mitochondrial stress identified as a key factor in rare myocarditis after messenger RNA vaccination
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Oct-2026 17:17 ET (23-Oct-2026 21:17 GMT/UTC)
Scientists at La Jolla Institute for Immunology (LJI) have discovered that the influenza vaccine FluMist can stimulate immunity in the upper airways of adults. This is the first time researchers have tracked how immune cells in the upper airways respond to an intranasal vaccine (given via a spray in the nose). The new study gives scientists a guide for measuring the effectiveness of new intranasal vaccines against RSV, COVID-19, and other respiratory diseases.
An international team led by Dr. Adolfo Poma (IPPT PAN, Poland) shows that antibody effectiveness depends not only on binding strength but also on their stability under mechanical forces. The findings provide a new framework for designing more robust antiviral therapeutics.
New research using data from the Canadian Longitudinal Study on Aging (CLSA) reveals that employment stability and in-person work buffered older adults against depression during the first year of COVID-19.